Home › Compare › CTIC vs YUM

CTIC vs YUM: Dividend Comparison 2026

CTIC yields 21.99% · YUM yields 1.85%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 YUM wins by $24.6K in total portfolio value· pulled ahead in Year 10
10 years
CTIC
CTIC
● Live price
21.99%
Share price
$9.10
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$82.4K
Annual income
$8,289.02
Full CTIC calculator →
YUM
YUM
● Live price
1.85%
Share price
$155.48
Annual div
$2.88
5Y div CAGR
51.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$107.0K
Annual income
$39,957.33
Full YUM calculator →

Portfolio growth — CTIC vs YUM

📍 YUM pulled ahead of the other in Year 10

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCTICYUM
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CTIC + YUM cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
CTIC pays
YUM pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CTIC
Annual income on $10K today (after 15% tax)
$1,869.16/yr
After 10yr DRIP, annual income (after tax)
$7,045.67/yr
YUM
Annual income on $10K today (after 15% tax)
$157.45/yr
After 10yr DRIP, annual income (after tax)
$33,963.73/yr
At 15% tax rate, YUM beats the other by $26,918.06/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CTIC + YUM for your $10,000?

CTIC: 50%YUM: 50%
100% YUM50/50100% CTIC
Portfolio after 10yr
$94.7K
Annual income
$24,123.17/yr
Blended yield
25.47%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on YUM right now

CTIC
Analyst Ratings
13
Buy
6
Hold
Consensus: Buy
Price Target
$10.40
+14.3% upside vs current
Range: $9.00 — $13.00
Altman Z
-27.1
Piotroski
3/9
YUM
Analyst Ratings
18
Buy
30
Hold
3
Sell
Consensus: Hold
Price Target
$173.15
+11.4% upside vs current
Range: $158.00 — $190.00
Altman Z
2.6
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CTIC buys
0
YUM buys
0
No recent congressional trades found for CTIC or YUM in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCTICYUM
Forward yield21.99% ✓1.85%
Annual dividend / share$2.00$2.88 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%51.4% ✓
Portfolio after 10y$82.4K$107.0K ✓
Annual income after 10y$8,289.02$39,957.33 ✓
Total dividends collected$49.2K$80.4K ✓
Payment frequencyquarterlyquarterly
SectorStockConsumer Discretionary
Analyst consensusBuyHold
Analyst price target$10.40$173.15 ✓

Year-by-year: CTIC vs YUM ($10,000, DRIP)

YearCTIC PortfolioCTIC Income/yrYUM PortfolioYUM Income/yrGap
1$12,899$2,199.01$10,980$280.44+$1.9K → CTIC
2$16,453$2,650.94$12,185$435.72+$4.3K → CTIC
3$20,765$3,160.11$13,722$684.14+$7.0K → CTIC
4$25,946$3,727.36$15,773$1,090.14+$10.2K → CTIC
5$32,114$4,352.67$18,650$1,773.02+$13.5K → CTIC
6$39,398$5,035.11$22,921$2,966.37+$16.5K → CTIC
7$47,928$5,772.90$29,685$5,158.69+$18.2K → CTIC
8$57,847$6,563.46$41,216$9,453.02+$16.6K → CTIC
9$69,299$7,403.48$62,672$18,571.31+$6.6K → CTIC
10← crossover$82,439$8,289.02$107,016$39,957.33$24.6K → YUM

CTIC vs YUM: Complete Analysis 2026

CTIC — Stock

CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of adult patients with myelofibrosis. It has license and collaboration agreement with Teva Pharmaceutical Industries Ltd.; S*BIO Pte Ltd.; and Baxalta. The company was formerly known as Cell Therapeutics, Inc. and changed its name to CTI BioPharma Corp. in May 2014. CTI BioPharma Corp. was incorporated in 1991 and is headquartered in Seattle, Washington.

Full CTIC Calculator →

YUM — Consumer Discretionary

YUM! Brands, Inc., together with its subsidiaries, develops, operates, and franchises quick service restaurants worldwide. It operates through four segments: the KFC Division, the Taco Bell Division, the Pizza Hut Division, and the Habit Burger Grill Division. The company operates restaurants under the KFC, Pizza Hut, Taco Bell, and The Habit Burger Grill brands, which specialize in chicken, pizza, made-to-order chargrilled burgers, sandwiches, Mexican-style food categories, and other food products. As of December 31, 2021, it had 26,934 KFC units; 18,381 Pizza Hut units; 7,791 Taco Bell units; and 318 The Habit Burger Grill units in approximately 157 countries and territories. The company was formerly known as TRICON Global Restaurants, Inc. and changed its name to YUM! Brands, Inc. in May 2002. YUM! Brands, Inc. was incorporated in 1997 and is headquartered in Louisville, Kentucky.

Full YUM Calculator →
📬

Get this CTIC vs YUM comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CTIC vs SCHDCTIC vs JEPICTIC vs OCTIC vs KOCTIC vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.